About Dermatophytic Onychomycosis

Dermatophytic onychomycosis is a fungal infection of the nail plate, nail bed, and, in some cases, the skin surrounding the nail plate. It is caused by yeast, dermatophytes, and molds; dermatophytes account for 90% of all cases. The fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, infects the skin, hair, or nails. It is often perceived by people to be an active and contagious infection. Onychomycosis may persist or worsen if not treated. The fungi that cause onychomycosis exist in common sites such as floors, soil, socks, and shoes. Therapies for onychomycosis include debridement and drugs. Debridement is time consuming and minimally effective in eradicating the fungal infection. Systemic drug treatment is most effective in treating onychomycosis.

Read more at: http://www.researchbeam.com/global-dermatophytic-onychomycosis-market

Researchbeam’s analysts forecast the global dermatophytic onychomycosis market to grow at a CAGR of 7.44% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global dermatophytic onychomycosis market for 2015-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used to treat and prevent onychomycosis.

The market is divided into the following segments based on geography:

APAC

EMEA

Americas

Researchbeam’s report, Global Dermatophytic Onychomycosis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

Anacor Pharmaceuticals

Galderma

Janssen Biotech

Novartis

Valeant Pharmaceuticals

Other prominent vendors

Abeona Therapeutics

Allergan

Elorac

GlaxoSmithKline

Hexima

Hisamitsu Pharmaceutical

Mayne Pharma

MediQuest Therapeutics

Meiji Seika Pharma

Merz Pharma

Moberg Pharma

NanoBio

NovaBiotics

Nuvo Research

Pfizer

Polichem

Promius Pharma

Sanofi

Seren Pharmaceuticals

Taro Pharmaceutical

Topica Pharmaceuticals

Viamet Pharmaceuticals

Market driver

Increase in R&D

For a full, detailed list, view our report

Market challenge

Adverse effects and limited efficacy of drugs

For a full, detailed list, view our report

Market trend

Increased focus on combination therapies

For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2020 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?

Request report sample @ http://www.researchbeam.com/global-dermatophytic-onychomycosis-market/enquire-about-report

Table of Contents

PART 01: Executive summary

• Highlights

PART 02: Scope of the report

Market overview

Top-vendors

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
Key market highlights
Key buying criteria

PART 05: Overview: Dermatophytic onychomycosis
Types of dermatophytic onychomycosis
Risk factors
Management
Epidemiology

PART 06: Pipeline analysis
TDT 067
P-3058
MOB-015
VT-1161
Luliconazole solution, 10%
ME1111
NP213
HXP124

PART 07: Market landscape
Market overview
Market size and forecast
Five forces analysis

About Us:

With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency. With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
U.S. & Canada Toll Free: + 1-800-910-6452
International: + 1-503-894-6022
UK: + 44-845-528-1300
India: +91 20 66346070
Fax : +1 (855) 550-5975
Email: help@researchbeam.com
Web: http://www.researchbeam.com